|
[Related PubMed/MEDLINE] Total Number of Papers: 91
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: Guo |
Long Form |
: guanosine |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2021 |
Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse Model. |
IMI, MDD |
2 |
2021 |
Effects of intranasal guanosine administration on brain function in a rat model of ischemic stroke. |
In-Guo |
3 |
2021 |
Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms. |
PNP |
4 |
2021 |
Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy. |
PI3K |
5 |
2020 |
Guanosine enhances glutamate uptake and oxidation, preventing oxidative stress in mouse hippocampal slices submitted to high glutamate levels. |
Glu |
6 |
2020 |
Guanosine protects against behavioural and mitochondrial bioenergetic alterations after mild traumatic brain injury. |
ETS, OXPHOS, RCR, TBI |
7 |
2020 |
Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A1 and A2A Receptors. |
ADO, ARs |
8 |
2020 |
Identification of guanine, guanosine, and inosine for alpha-amylase inhibitors in the extracts of the earthworm Eisenia fetida and characterization of their inhibitory activities against porcine pancreatic alpha-amylase. |
Gua, Ino, PPA, SPE |
9 |
2020 |
Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice. |
PD, ROS, TJMs |
10 |
2019 |
A1 rather than A2A adenosine receptor as a possible target of Guanosine effects on mitochondrial dysfunction following Traumatic Brain Injury in rats. |
CNS, FPI, TBI |
11 |
2019 |
Amino acid-linked platinum(II) compounds: non-canonical nucleoside preferences and influence on glycosidic bond stabilities. |
AAPt, ADO, CisPt, dAdo, dGuo |
12 |
2019 |
Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors. |
CaMKII, ERK, GBPs, GMP, GMP, NMDA, PI3K, PKA, PKC |
13 |
2019 |
Guanosine Prevents against Glutamatergic Excitotoxicity in C. elegans. |
WT |
14 |
2019 |
Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine. |
DLS, PD, PFC |
15 |
2019 |
Guanosine protects against Ca2+-induced mitochondrial dysfunction in rats. |
--- |
16 |
2019 |
Long lasting behavioral and electrophysiological action of early administration of guanosine: Analysis in the adult rat brain. |
CSD, EPM |
17 |
2018 |
Guanosine Attenuates Behavioral Deficits After Traumatic Brain Injury by Modulation of Adenosinergic Receptors. |
TBI |
18 |
2018 |
Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion. |
PD, ROS |
19 |
2018 |
Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats. |
--- |
20 |
2018 |
New gold pincer-type complexes: synthesis, characterization, DNA binding studies and cytotoxicity. |
5'-GMP, CT-DNA, Me2LtBu, 2, ROS |
21 |
2018 |
Uncovering the Signaling Pathway behind Extracellular Guanine-Induced Activation of NO System: New Perspectives in Memory-Related Disorders. |
GDA, Gua, PNP |
22 |
2017 |
Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder. |
PD |
23 |
2017 |
Delayed administration of guanosine improves long‑term functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke. |
BDNF, BrdU, NeuN, VEGF |
24 |
2017 |
Gas-Phase Conformations and N-Glycosidic Bond Stabilities of Sodium Cationized 2'-Deoxyguanosine and Guanosine: Sodium Cations Preferentially Bind to the Guanine Residue. |
dGuo, ER-CID, IRMPD |
25 |
2017 |
Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells. |
TMZ |
26 |
2016 |
Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication. |
CSF, EEG, i.p |
27 |
2016 |
Guanosine may increase absence epileptic activity by means of A2A adenosine receptors in Wistar Albino Glaxo Rijswijk rats. |
A2AR, ADO, i.p, LPS, QA, SWDs |
28 |
2016 |
Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation. |
GS, OGD |
29 |
2016 |
Regulation of Mitochondrial Function and Glutamatergic System Are the Target of Guanosine Effect in Traumatic Brain Injury. |
FPI, TBI |
30 |
2015 |
Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats. |
a,d, ADO, CNS, GABAA receptors, i.p, Ino, NMDA, non-Ado, PTZ, QA, SWDs, Urd |
31 |
2015 |
Effects of nucleosides on glia - neuron interactions open up new vistas in the development of more effective antiepileptic drugs. |
ADO, CNS, Ino, Urd |
32 |
2015 |
Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats. |
--- |
33 |
2015 |
Modulatory effects of inosine, guanosine and uridine on lipopolysaccharide-evoked increase in spike-wave discharge activity in Wistar Albino Glaxo/Rijswijk rats. |
i.p, Ino, LPS, non-Ado, SWDs, Urd |
34 |
2014 |
Guanosine protects glial cells against 6-hydroxydopamine toxicity. |
DA, PD |
35 |
2014 |
Non-adenosine nucleoside inosine, guanosine and uridine as promising antiepileptic drugs: a summary of current literature. |
ADO, CNS, Ino, non-Ado, Urd |
36 |
2014 |
Total inhibition of (1)O2-induced oxidative damage to guanine bases of DNA/RNA by turmeric extracts. |
--- |
37 |
2013 |
5'-nucleotidases, nucleosides and their distribution in the brain: pathological and therapeutic implications. |
ADO, CNS, Ino, Urd |
38 |
2013 |
G-quadruplex guanosine gels and single walled carbon nanotubes. |
G-gels, GMP, SWNTs |
39 |
2013 |
Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. |
A2AR, OGD |
40 |
2013 |
The antiepileptic potential of nucleosides. |
ADK, ADO, Ino, non-Ado, Urd |
41 |
2012 |
Cooperation of non-effective concentration of glutamatergic system modulators and antioxidant against oxidative stress induced by quinolinic acid. |
QA, ROS, TBARS |
42 |
2012 |
Efficient determination of purine metabolites in brain tissue and serum by high-performance liquid chromatography with electrochemical and UV detection. |
ADO, Gua, HPLC, Hyp, Ino, LOD, UA, Xan |
43 |
2012 |
Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. |
5'-GMP, 9MeG |
44 |
2012 |
Guanosine protects against reperfusion injury in rat brains after ischemic stroke. |
ER, IL-8, MCAO, OGD, ROS |
45 |
2012 |
Supramolecular arrangement of guanosine/5-guanosine monophosphate binary mixtures studied by methods of circular dichroism. |
GMP |
46 |
2011 |
Alkylating potential of alpha,beta-unsaturated compounds. |
AA, AC, alpha,beta-UC, AM, AN |
47 |
2011 |
Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion. |
BDNF, CSF |
48 |
2011 |
Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. |
ER, MCAO |
49 |
2010 |
Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. |
AD |
50 |
2009 |
Analysis of an RNA adduct formed from aminophenylnorharman. |
--- |
51 |
2009 |
Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine. |
DRF, i.p, Ino, MN |
52 |
2009 |
Quantitative determination of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxo-7,8-dihydroguanine, 8-oxo-7,8-dihydroguanosine, and their non-oxidized forms: daily concentration profile in healthy volunteers. |
8-oxodGuo, 8-oxoGua, 8-oxoGuo, dGuo, Gua |
53 |
2009 |
The effect of preservation solutions UW and EC on purine concentration in rat kidney. |
ADO, ADP, AMP, ATP, EC, GMP, HPLC, Hyp, IMP, Ino, TAN, UW, Xan |
54 |
2008 |
Cyclic tetranuclear half-sandwich ruthenium(II) complexes with 4,7-phenanthroline and hydroxo bridges: crystal structure, solution behaviour and binding to nucleosides. |
Cyt, dAdo, phen |
55 |
2008 |
Extracellular guanosine and GTP promote expression of differentiation markers and induce S-phase cell-cycle arrest in human SH-SY5Y neuroblastoma cells. |
GTP |
56 |
2008 |
Guanosine promotes B16F10 melanoma cell differentiation through PKC-ERK 1/2 pathway. |
PKC, PLC |
57 |
2008 |
Importance of schedule of administration in the therapeutic efficacy of guanosine: early intervention after injury enhances glutamate uptake in model of hypoxia-ischemia. |
HI |
58 |
2008 |
Neurotrophic effects of extracellular guanosine. |
CNS, ecto-PNP, eGUA |
59 |
2008 |
Tunable thermoassociation of binary guanosine gels. |
CD, GMP |
60 |
2007 |
Guanine derivatives modulate extracellular matrix proteins organization and improve neuron-astrocyte co-culture. |
ECM, GD, GMP, MAPK, PKA, PKC |
61 |
2007 |
Oxypurine and purine nucleoside concentrations in renal vein of allograft are potential markers of energy status of renal tissue. |
AMP, ATP, HPLC, Hyp, Ino, UA, Urd, Xan |
62 |
2007 |
Role of ionization of the phosphate cosubstrate on phosphorolysis by purine nucleoside phosphorylase (PNP) of bacterial (E. coli) and mammalian (human) origin. |
Ino, PNP |
63 |
2006 |
Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells. |
LC-MS, MS, ONE |
64 |
2006 |
Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. |
ADO, ADP, AEC, AMP, ATP, GDP, GMP, GTP, Hyp, IMP, Ino, NAD, NADP, TAN, TMZ, UA, Urd, Xan |
65 |
2006 |
GTP induces S-phase cell-cycle arrest and inhibits DNA synthesis in K562 cells but not in normal human peripheral lymphocytes. |
GPA, GTP, PBL |
66 |
2006 |
Guanosine promotes the up-regulation of inward rectifier potassium current mediated by Kir4.1 in cultured rat cortical astrocytes. |
--- |
67 |
2005 |
Chromatographic separation of nucleosides using a cross-linked xylose isomerase crystal stationary phase. |
ADO, Cyd, Urd |
68 |
2005 |
Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine. |
HI |
69 |
2004 |
Anticonvulsant effect of GMP depends on its conversion to guanosine. |
CSF, GMP, i.p, QA |
70 |
2004 |
Effect of lead ions on rat erythrocyte purine content. |
ATP, ADP, and AMP, HPLC, Hyp, IMP, Ino |
71 |
2004 |
Formamidopyrimidines as major products in the low- and high-intensity UV irradiation of guanine derivatives. |
--- |
72 |
2003 |
Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. |
--- |
73 |
2002 |
Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. |
5'-GMP |
74 |
2002 |
Potentiating effect of mizoribine on the anti-herpes virus activity of acyclovir. |
ACV, dNTP, HESMF, HSV-1, MZR |
75 |
2002 |
Purine nucleoside phosphorylase from Cellulomonas sp.: physicochemical properties and binding of substrates determined by ligand-dependent enhancement of enzyme intrinsic fluorescence, and by protective effects of ligands on thermal inactivation of the enzyme. |
Gua, HX, Ino, PNP, R1P |
76 |
2002 |
Xanthosine and xanthine. Substrate properties with purine nucleoside phosphorylases, and relevance to other enzyme systems. |
Gua, HX, Ino, PNP, Xan, Xao |
77 |
2001 |
Separation of inosine, hypoxanthine, and guanosine by high-performance liquid chromatography on silica. |
Hyp, Ino |
78 |
2000 |
Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. |
ADA, ADO, EHNA |
79 |
2000 |
Mechanism of formation of guanine as one of the major products in the 254 nm photolysis of guanine derivatives: concentration and pH effects. |
dGuo, GMP, Gua |
80 |
2000 |
Photochemical and photophysical studies of guanine derivatives: intermediates contributing to its photodestruction mechanism in aqueous solution and the participation of the electron adduct. |
Gua |
81 |
1997 |
Mechanism and intermediate for formation of 2'-deoxyoxanosine. |
1-MeGuo, dGuo, dOxo, NO, Oxo, RP, Xao |
82 |
1994 |
Epitope complementarity and idiotypic interactions: a study of idiotypic-like interactions between anti-cytidine and anti-guanosine A/J mouse monoclonal antibodies--I. Characterization of these interactions. |
Cyd |
83 |
1993 |
Optimized separation of purine bases and nucleosides in human cord plasma by capillary zone electrophoresis. |
Ade, ADO, Gua, Hyp, Ino, UA, Xan |
84 |
1992 |
Relaxation kinetics of ribonuclease T1 binding with guanosine and 3'-GMP. |
eq, RNase T1 |
85 |
1992 |
Substitution of p- and o-hydroxyphenyl radicals at the 8 position of purine nucleosides by reaction with mutagenic p- and o-diazoquinones. |
dAdo, dGuo |
86 |
1990 |
Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency. |
dGTP, dGuo, PNP |
87 |
1988 |
Reaction of trans-4-N-acetoxy-N-acetylaminostilbene with guanosine and deoxyguanosine in vitro: the primary reaction product at N2 of guanine yields different final adducts. |
dGuo, Gua, N-acetoxy-AAS |
88 |
1986 |
Aminations of guanosine and deoxyguanosine with hydroxylamine-O-sulfonic acid and 2,4-dinitrophenoxyamine. Dependence on the reaction medium. |
dG |
89 |
1984 |
Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia. |
FdUrd, FUra, FUrd |
90 |
1984 |
Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo. |
dGuo, DTH, GVH, HVG, s.c |
91 |
1976 |
Ribose recognition by ribonuclease T1: difference spectral binding studies with guanosine and deoxyguanosine. |
dGuo |
|